Kusatsu, Japan

Hiroshi Imoto



Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Kusatsu, JP (2001 - 2007)
  • Osaka, JP (2009 - 2013)
  • Fujisawa, JP (2018)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Hiroshi Imoto

Introduction

Hiroshi Imoto is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide compounds and heterocyclic compounds. With a total of nine patents to his name, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Among his latest patents, Imoto has developed GIP receptor agonist peptide compounds. These compounds are designed to activate GIP receptors and are intended for use as medicaments in the treatment and prevention of diabetes, obesity, and related conditions. The specific peptide sequence is represented by a complex formula, which highlights the innovative nature of his work. Additionally, he has created a heterocyclic compound that exhibits orexin receptor antagonistic activity, which may be beneficial in treating sleep disorders, depression, and other mental health issues.

Career Highlights

Hiroshi Imoto has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Imoto has collaborated with notable coworkers such as Yu Momose and Hiroyuki Odaka. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Hiroshi Imoto's innovative work in the field of medicinal chemistry showcases his dedication to improving health outcomes through scientific advancements. His contributions, particularly in the area of peptide and heterocyclic compounds, hold promise for the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…